|
|
|
IMS Health, Bristol-Myers Squibb Ink Pact
|
Business New Haven
8/7/2000
By: Kristine Hansen
|
| LONDON - IMS Health (NYSE: RX) announced that United Kingdom-based Bristol-Myers Squibb Pharmaceuticals Ltd. has signed a three-year agreement for the implementation of the IMS Health Strategic Technologies' Premiere Pharmaceutical Relationship Management (PRM) solutions and for the expansion of its use of the company's Pharbase IMS Health Strategic Technologies pharmaceutical marketing database. It is expected that 400 Bristol-Myers Squibb marketing and sales
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
